Conmed (MEX:CNMD) Cyclically Adjusted FCF per Share: MXN69.95 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:CNMD Conmed Corp MEX:CNMD
80 GF Score
Price MXN720.00
GF Value MXN945.33
! 5 Warning Signs
View Full Analysis

What is Conmed Cyclically Adjusted FCF per Share?

Conmed MEX:CNMD 80 Cyclically Adjusted FCF per Share is MXN69.95 as of Jun. 2026. GuruFocus rates MEX:CNMD with a GF Score™ of 80/100 and a GF Value™ of MXN945.33. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Conmed's adjusted free cash flow per share for the three months ended in Jun. 2026 was MXN19.792. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN69.95 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Conmed's average Cyclically Adjusted FCF Growth Rate was 17.80% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 11.70% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 5.70% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 5.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Conmed was 11.70% per year. The lowest was -1.80% per year. And the median was 5.20% per year.

As of today (2026-08-21), Conmed's current stock price is MXN720.00. Conmed's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was MXN69.95. Conmed's Cyclically Adjusted Price-to-FCF of today is 10.29.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Conmed was 70.84. The lowest was 10.54. And the median was 38.61.


Conmed  (MEX:CNMD) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Conmed's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=720.00/69.95
=10.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Conmed was 70.84. The lowest was 10.54. And the median was 38.61.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Conmed Cyclically Adjusted FCF per Share Related Terms


Conmed Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Conmed's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Conmed Cyclically Adjusted FCF per Share Chart

Conmed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.29 38.43 38.02 53.75 58.73

Conmed Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 75.38 87.18 58.73 62.92 69.95

MEX:CNMD vs ATEC, AORT, IRMD: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Conmed's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Conmed Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Conmed's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Conmed's Cyclically Adjusted Price-to-FCF falls into.


MEX:CNMD
80GF Score
Conmed Corp MEX:CNMD
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Conmed Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Conmed's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=19.792/333.9520*333.9520
=19.792

Current CPI (Jun. 2026) = 333.9520.

Conmed Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 15.214 241.428 21.045
201612 6.899 241.432 9.543
201703 8.591 243.801 11.768
201706 8.407 244.955 11.461
201709 6.260 246.819 8.470
201712 11.933 246.524 16.165
201803 13.504 249.554 18.071
201806 11.660 251.989 15.453
201809 -0.070 252.439 -0.093
201812 13.532 251.233 17.987
201903 -5.306 254.202 -6.971
201906 10.865 256.143 14.165
201909 21.027 256.759 27.349
201912 21.865 256.974 28.415
202003 0.707 258.115 0.915
202006 1.445 257.797 1.872
202009 23.903 260.280 30.669
202012 10.477 260.474 13.432
202103 12.531 264.877 15.799
202106 19.183 271.696 23.579
202109 10.099 274.310 12.295
202112 19.134 278.802 22.919
202203 -1.902 287.504 -2.209
202206 8.805 296.311 9.924
202209 12.405 296.808 13.957
202212 -11.048 296.797 -12.431
202303 -4.680 301.836 -5.178
202306 11.940 305.109 13.069
202309 22.390 307.789 24.293
202312 27.770 306.746 30.233
202403 14.375 312.332 15.370
202406 23.391 314.175 24.863
202409 30.242 315.301 32.031
202412 26.306 315.605 27.835
202503 24.795 319.799 25.892
202506 14.191 322.561 14.692
202509 28.653 324.800 29.460
202512 23.820 324.054 24.548
202603 6.231 330.213 6.302
202606 19.792 333.952 19.792

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of MXN69.95 mean?
Conmed (MEX:CNMD) has a Cyclically Adjusted FCF per Share of MXN69.95 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Conmed and its competitors.
Is Conmed's Cyclically Adjusted FCF per Share too high?
Conmed's current Cyclically Adjusted FCF per Share is MXN69.95. Overall, Conmed has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Conmed's Cyclically Adjusted FCF per Share compare to ATEC and AORT?
Conmed's Cyclically Adjusted FCF per Share of MXN69.95 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Conmed and its competitors. Conmed's current Cyclically Adjusted FCF per Share is MXN69.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conmed stock overvalued right now?
Conmed (MEX:CNMD) has a current Cyclically Adjusted FCF per Share of MXN69.95. The stock's GF Value™ is MXN945.33, compared to a current price of MXN720.00 — trading 23.8% below its estimated fair value. The current Cyclically Adjusted FCF per Share is MXN69.95. Conmed's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Conmed (MEX:CNMD), the current Cyclically Adjusted FCF per Share is MXN69.95 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Conmed (MEX:CNMD) Overvalued in 2026?

Based on GuruFocus' analysis, Conmed stock appears to be undervalued. The current stock price of MXN720.00 is trading 23.8% below its estimated GF Value™ of MXN945.33.

Key valuation signals for MEX:CNMD:

  • Cyclically Adjusted FCF per Share: MXN69.95
  • GF Value™: MXN945.33 vs. price of MXN720.00 (23.8% below fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the MEX:CNMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Conmed Business Description

Other Exchanges CNMD:USA
Address 11311 Concept Boulevard, Largo, FL, USA, 33773
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
80GF Score

Get the complete analysis for MEX:CNMD

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN720.00
Price
MXN945.33
GF Value